(Q37760955)

22 August 2017

1 reference

title

Personalized therapy in pain management: where do we stand? (English)

1 reference

22 August 2017

0 references

Ulrike M Stamer

1

1 reference

22 August 2017

Lan Zhang

series ordinal

2

1 reference

22 August 2017

Frank Stüber

series ordinal

3

1 reference

22 August 2017

publication date

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

11

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

843-864

1 reference

Persistent postsurgical pain: risk factors and prevention

22 August 2017

cites work

1 reference

Transition from acute to chronic postsurgical pain: risk factors and protective factors

21 January 2018

1 reference

Variable response to opioid treatment: any genetic predictors within sight?

21 January 2018

1 reference

Genetic modulation of the pharmacological treatment of pain

21 January 2018

1 reference

Pharmacogenetics of analgesics: toward the individualization of prescription

21 January 2018

1 reference

Pharmacogenetics in drug regulation: promise, potential and pitfalls

21 January 2018

1 reference

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

21 January 2018

1 reference

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme

21 January 2018

1 reference

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

21 January 2018

1 reference

Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.

21 January 2018

1 reference

Codeine intoxication associated with ultrarapid CYP2D6 metabolism

21 January 2018

1 reference

Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer.

21 January 2018

1 reference

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

21 January 2018

1 reference

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

21 January 2018

1 reference

Codeine phosphate in paediatric medicine

21 January 2018

1 reference

Codeine and morphine pathway

21 January 2018

1 reference

Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan

21 January 2018

1 reference

Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability

21 January 2018

1 reference

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.

21 January 2018

1 reference

Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?

21 January 2018

1 reference

Codeine, ultrarapid-metabolism genotype, and postoperative death

21 January 2018

1 reference

Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer

21 January 2018

1 reference

Establishing causality of CNS depression in breastfed infants following maternal codeine use.

21 January 2018

1 reference

Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study

21 January 2018

1 reference

Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans

21 January 2018

1 reference

The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers

21 January 2018

1 reference

CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone.

21 January 2018

1 reference

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.

21 January 2018

1 reference

Tramadol: a review of its use in perioperative pain

21 January 2018

1 reference

Tramadol, M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9.10 neuroblastoma cells

21 January 2018

1 reference

The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6.

21 January 2018

1 reference

Impact of CYP2D6 genotype on postoperative tramadol analgesia

21 January 2018

1 reference

Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.

21 January 2018

1 reference

Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol

21 January 2018

1 reference

Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites

21 January 2018

1 reference

Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia

21 January 2018

1 reference

The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism

21 January 2018

1 reference

Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone

21 January 2018

1 reference

Methadone use in cancer patients with pain: a review

21 January 2018

1 reference

Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.

21 January 2018

1 reference

Development and psychometric properties of the Verona Service Satisfaction Scale for methadone-treated opioid-dependent patients (VSSS-MT).

21 January 2018

1 reference

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

21 January 2018

1 reference

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy

21 January 2018

1 reference

Clinical consequences of cytochrome P450 2C9 polymorphisms

21 January 2018

1 reference

Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?

21 January 2018

1 reference

Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites

21 January 2018

1 reference

CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers

21 January 2018

1 reference

In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics

21 January 2018

1 reference

Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.

21 January 2018

1 reference

The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.

21 January 2018

1 reference

Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms

21 January 2018

1 reference

CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians

21 January 2018

1 reference

Pharmacogenetic relevance of the CYP2C9*3 allele in a tenoxicam bioequivalence study performed on Spaniards.

21 January 2018

1 reference

Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam.

21 January 2018

1 reference

Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans

21 January 2018

1 reference

Effect of the CYP2C9*3 allele on lornoxicam metabolism

21 January 2018

1 reference

Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers

21 January 2018

1 reference

Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies

21 January 2018

1 reference

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

21 January 2018

1 reference

Allele variants of the cytochrome P450 2C9 genotype in white subjects from The Netherlands with serious gastroduodenal ulcers attributable to the use of NSAIDs.

21 January 2018

1 reference

Clinically important drug interactions with anticoagulants. An update

21 January 2018

1 reference

Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants

21 January 2018

1 reference

Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans

21 January 2018

1 reference

Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.

21 January 2018

1 reference

Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers

21 January 2018

1 reference

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence

21 January 2018

1 reference

ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals

21 January 2018

1 reference

The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.

21 January 2018

1 reference

Novel linkage disequilibrium of single nucleotide polymorphisms in the transcriptional regulatory region of micro-opioid receptor gene in Japanese population

21 January 2018

1 reference

Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty

21 January 2018

1 reference

Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy

21 January 2018

1 reference

A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain

21 January 2018

1 reference

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease

21 January 2018

1 reference

Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment

21 January 2018

1 reference

A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain

21 January 2018

1 reference

High post surgical opioid requirements in Crohn's disease are not due to a general change in pain sensitivity

21 January 2018

1 reference

Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women

21 January 2018

1 reference

One size does not fit all: genetic variability of mu-opioid receptor and postoperative morphine consumption

21 January 2018

1 reference

Replicating genotype-phenotype associations

21 January 2018

1 reference

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor

21 January 2018

1 reference

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients

21 January 2018

1 reference

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene

21 January 2018

1 reference

Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament

21 January 2018

1 reference

Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans

21 January 2018

1 reference

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain

21 January 2018

1 reference

Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects

21 January 2018

1 reference

Progress in genetic studies of pain and analgesia

21 January 2018

1 reference

Genetic contributions to clinical pain and analgesia: avoiding pitfalls in genetic research

21 January 2018

1 reference

Genome-wide association study of acute post-surgical pain in humans

21 January 2018

1 reference

Pharmacogenetics of opioids

21 January 2018

1 reference

Influence of psychological factors on risk of temporomandibular disorders.

21 January 2018

1 reference

Evidence for a biopsychosocial influence on shoulder pain: pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain ratings.

21 January 2018

1 reference

Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers

21 January 2018

1 reference

Effect of CYP2C9*3 allele on the pharmacokinetics of naproxen in Korean subjects

21 January 2018

1 reference

Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.

21 January 2018

1 reference

A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia

21 January 2018

1 reference

Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype.

21 January 2018

1 reference

Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery

21 January 2018

1 reference

Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain

21 January 2018

1 reference

Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery

21 January 2018

1 reference

Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study

21 January 2018

1 reference

ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

21 January 2018

1 reference

No Influence of ABCB1 Haplotypes on Methadone Dosage Requirement

21 January 2018

1 reference

Environmental and genetic factors associated with morphine response in the postoperative period

21 January 2018

1 reference

Genetic Susceptibility to Nonsteroidal Anti-Inflammatory Drug–Related Gastroduodenal Bleeding: Role of Cytochrome P450 2C9 Polymorphisms

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.10.47

1 reference

22 August 2017

1 reference